Jushi Holdings (JUSHF) Cash & Equivalents (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Cash & Equivalents of $33.3 million for Q2 2026, up 43.62% year-over-year from $23.2 million in Q2 2025, and down 16.05% quarter-over-quarter from $39.7 million in Q1 2026.
Jushi Holdings (JUSHF) Cash & Equivalents (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Cash & Equivalents for 6 consecutive years, with $33.3 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash & Equivalents rose 43.62% year-over-year to $33.3 million; the TTM figure through Jun 2026 stood at $33.3 million (up 43.62% YoY), while the FY2025 annual figure was $24.0 million, up 23.19% from the prior year.
- Cash & Equivalents declined to $33.3 million in Q2 2026 per JUSHF's latest filing, from $39.7 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $43.2 million in Q2 2022 and bottomed at $18.5 million in Q1 2023.
- Historically, Cash & Equivalents has averaged $27.3 million across 5 years, with a median of $26.0 million in 2025.
- Annual changes were most pronounced in 2022 — Cash & Equivalents tumbled 72.41% — and 2026, when it soared 52.92%.
- Jushi Holdings' Cash & Equivalents stood at $26.2 million in 2022, then decreased by 0.65% to $26.0 million in 2023, then dropped by 25.0% to $19.5 million in 2024, then increased by 23.19% to $24.0 million in 2025, then soared by 38.6% to $33.3 million in 2026.
- Business Quant data shows JUSHF's Cash & Equivalents at $33.3 million in Q2 2026, $39.7 million in Q1 2026, and $24.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 164.00 Mn |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | 33.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.33 Mn |
| Mar 31, 2026 | 39.70 Mn |
| Dec 31, 2025 | 24.05 Mn |
| Sep 30, 2025 | 23.17 Mn |
| Jun 30, 2025 | 23.21 Mn |
| Mar 31, 2025 | 25.96 Mn |
| Dec 31, 2024 | 19.52 Mn |
| Sep 30, 2024 | 20.74 Mn |
| Jun 30, 2024 | 32.88 Mn |
| Mar 31, 2024 | 25.29 Mn |
| Dec 31, 2023 | 26.03 Mn |
| Sep 30, 2023 | 25.01 Mn |
| Jun 30, 2023 | 26.78 Mn |
| Mar 31, 2023 | 18.47 Mn |
| Dec 31, 2022 | 26.20 Mn |
| Sep 30, 2022 | 31.06 Mn |
| Jun 30, 2022 | 43.19 Mn |
| Dec 31, 2021 | 94.96 Mn |